News from thoratec corporation A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

May 26, 2015, 16:25 ET

Thoratec Presentation At Goldman Sachs Healthcare Conference To Be Webcast

Thoratec Corporation (NASDAQ: THOR), a world leader in mechanical circulatory support therapies to save, support and restore failing hearts, said...

May 26, 2015, 09:00 ET

Thoratec Receives Conditional FDA Approval For The Shield II U.S. Clinical Trial For HeartMate PHP

Thoratec Corporation (NASDAQ: THOR), a world leader in mechanical circulatory support therapies to save, support and restore failing hearts,...

May 07, 2015, 16:02 ET

Thoratec® Reports First Quarter 2015 Results

 Thoratec Corporation (NASDAQ: THOR), a world leader in mechanical circulatory support (MCS) therapies to save, support and restore failing...

May 01, 2015, 09:00 ET

Thoratec Announces Addition To Senior Management Team

 Thoratec Corporation (NASDAQ: THOR), a world leader in mechanical circulatory support therapies to save, support and restore failing hearts,...

Apr 30, 2015, 16:20 ET

Thoratec Presentation At Bank Of America Merrill Lynch Healthcare Conference To Be Webcast

 Thoratec Corporation (NASDAQ: THOR), a world leader in mechanical circulatory support therapies to save, support and restore failing hearts,...

Apr 20, 2015, 09:10 ET

Thoratec Schedules First Quarter Conference Call, Webcast

Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing...

Apr 17, 2015, 03:30 ET

ROADMAP Study Demonstrates HeartMate II® Benefits In Ambulatory Advanced Heart Failure Patients

Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing...

Apr 16, 2015, 09:49 ET

Thoratec Comments On HeartMate II® Data In ENDURANCE Destination Therapy Trial

 Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore...

Apr 06, 2015, 08:45 ET

Thoratec To Webcast Investor Meeting At ISHLT Conference

 Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore...

Apr 02, 2015, 09:00 ET

Thoratec Receives Approval From FDA For Full Expansion Of HeartMate III™ U.S. IDE Clinical Trial

 Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore...

Feb 25, 2015, 08:45 ET

Thoratec Announces Presentations At Investor Conferences For March 2015

Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing...

Feb 10, 2015, 16:02 ET

Thoratec® Reports Fourth Quarter 2014 Results

Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing...

Jan 30, 2015, 08:45 ET

Thoratec Presentation At Leerink Global Healthcare Conference To Be Webcast

 Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore...

Jan 28, 2015, 17:26 ET

Thoratec Schedules Fourth Quarter Conference Call, Webcast

Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing...

Jan 02, 2015, 16:09 ET

Thoratec Presentation At J.P. Morgan Healthcare Conference To Be Webcast

 Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore...

Dec 01, 2014, 09:00 ET

Thoratec gibt die Beendigung des Patienteneinschlusses für die HeartMate III™ CE-Zulassungsstudie bekannt

Thoratec Corporation (NASDAQ: THOR), ein weltweit führendes Unternehmen von mechanischen Kreislaufunterstützungstherapien zur Rettung,...

Dec 01, 2014, 09:00 ET

Thoratec Announces Completion Of Enrollment In The HeartMate III™ CE Mark Trial

 Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore...

Nov 26, 2014, 09:00 ET

Thoratec Announces Presentations At Investor Conferences For December 2014

 Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore...

Nov 06, 2014, 09:15 ET

Thoratec Announces Presentations At Investor Conferences For November 2014

Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing...

Nov 05, 2014, 16:02 ET

Thoratec® Reports Third Quarter 2014 Results

 Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore...